AGP Picks
View all

AGP Executive Report

Last update: 11 hours ago

Heat & safety: A partial solar eclipse on Wednesday could briefly cool parts of the UK during the ongoing heatwave, with experts estimating temperature drops of a few degrees for about an hour as the Moon covers up to around 90%+ of the Sun. Eye protection: Health authorities and astronomy groups stress that eclipse viewing still requires certified eclipse glasses or safe indirect viewing—direct staring can cause permanent eye damage. Iceland emergency response: Rescue teams in Árnessýsla carried out a challenging overnight operation after a solo hiker was injured near Háifoss, with ICE-SAR and a Coast Guard helicopter involved. Public health watch: WHO says DR Congo’s Ebola outbreak began months before it was officially declared, after genetic sequencing; confirmed cases have reached 4,200 with more than 1,900 deaths. Local safety incident: Police in Kópavogur are treating a death after a serious assault as a homicide, with multiple arrests and an active investigation. Health research/industry: Oculis agreed to buy Accure’s rights to Privosegtor, a neuroprotective candidate in trials for optic neuropathies and acute MS relapses. Wellness travel trend: “Coolcation” travel is rising as people choose cooler destinations like Iceland to stay active outdoors despite climate-driven heat.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Jul. 17, 2026

Flavored milk powder drinks market seen reaching $14.87 billion by 2030

AGP

fallback image
Jul. 17, 2026

Flavored milk powder drinks market seen reaching $14.87 billion by 2030

AGP

fallback image
Jul. 13, 2026

Twiggle tea packaging wins Iron A' Design Award

AGP

fallback image
Jul. 3, 2026

European Commission authorizes CinnaGen’s osteoporosis biosimilar Zandoriah in EU

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Best lohud girls soccer player, presented by White Plains Hospital Here are 10 of the greatest high school girls soccer stars from this area, with collegiate and professional success also considered. Who is your GOAT? Read More

Best lohud girls soccer player, presented by White Plains Hospital Here are 10 of the greatest high school girls soccer stars from this area, with collegiate and professional success also considered. Who is your GOAT? Read More

From Jodrell Bank to Rivington: These are the best Greater Manchester spots to watch the rare 90% solar eclipse this Wednesday – when you can see the peak & health advice from experts

From Jodrell Bank to Rivington: These are the best Greater Manchester spots to watch the rare 90% solar eclipse this Wednesday – when you can see the peak & health advice from experts

How to watch Solar Eclipse safely with common kitchen item as experts issue health warning

How to watch Solar Eclipse safely with common kitchen item as experts issue health warning

Ivanka Trump ridiculed over Iceland vacation as critics ask 'did you discover this land also?'

Ivanka Trump ridiculed over Iceland vacation as critics ask 'did you discover this land also?'

China’s Gan & Lee Soars After Selling Rights to Weight Loss Drug in Europe to Menarini for USD839 Million

China’s Gan & Lee Soars After Selling Rights to Weight Loss Drug in Europe to Menarini for USD839 Million


fallback image
Aug. 10, 2026

Alvotech to Report Financial Results for H1 2026

GlobeNewswire, Inc.

fallback image
Aug. 10, 2026

Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company

GlobeNewswire, Inc.

fallback image
Jul. 24, 2026

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

GlobeNewswire, Inc.

fallback image
Jul. 9, 2026

Icelandirect Earns SSCI Certification, Strengthening Its Ability to Serve Brands Selling Across Major Retail Channels

GlobeNewswire, Inc.

fallback image
Jul. 1, 2026

SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma

GlobeNewswire, Inc.

fallback image
Aug. 6, 2026

Oculis Reports Q2 2026 Financial Results and Provides Company Update

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: Why Greece's $1 Billion Feta Industry Could Be at Risk
Play
Why Greece's $1 Billion Feta Industry Could Be at Risk
YouTube video thumbnail: Serbia's Vučić Sends Signal to Brussels and Moscow by Hosting Zelenskyy With Pomp and Circumstance
Play
Serbia's Vučić Sends Signal to Brussels and Moscow by Hosting Zelenskyy With Pomp and Circumstance
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: Russia and Ukraine Exchange Deadly Overnight Strikes
Play
Russia and Ukraine Exchange Deadly Overnight Strikes
YouTube video thumbnail: EU's New Border Entry System Causing Long Lines at Airports
Play
EU's New Border Entry System Causing Long Lines at Airports

Video Title

Sign up for:

Iceland Health Focus

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Iceland Health Focus

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.